Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085834 · ClinicalTrials.gov registry record · Early Phase 1
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
A Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 95
- Enrollment target
NCT05085834: Completed Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
NCT05085834 is a Early Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 95 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05085834, a Early Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 95 participants
- Enrollment target
Study Summary
To study the effect of short-term zinc supplementation on improving inflammation, metabolic, and cardiovascular risk among HIV infected patients on stable anti-retroviral therapy
Primary Outcome
Changes in zinc levels after zinc supplementation in HIV-infected subjects with zinc deficiency
Interventions
- DRUG Placebo
- DRUG Zinc Gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2024-08-02 |
| Phase | Early Phase 1 |
What the finished NCT05085834 record still lists
NCT05085834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05085834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05085834 about?
NCT05085834 is a clinical study titled "Zinc Effect on Inflammation and Cardiovascular Risk in HIV". To study the effect of short-term zinc supplementation on improving inflammation, metabolic, and cardiovascular risk among HIV infected patients on stable anti-retroviral therapy
What is the current status of trial NCT05085834?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 95 participants. The study started on 2020-01-22. Estimated completion is 2024-08-02.
What interventions are being tested in trial NCT05085834?
The interventions under investigation include: Placebo (DRUG), Zinc Gluconate (DRUG).
Who is sponsoring clinical trial NCT05085834?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05085834's enrollment target sits among peer trials
95 226th of 2000 higher than 1,774 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI